Covid-19 Immunity Task Force Databank

From April 2020 to March 2023, the Covid-19 Immunity Task Force (CITF) supported 120 studies to generate knowledge about immunity to SARS-CoV-2. The subjects addressed by these studies include the extent of SARS-CoV-2 infection in Canada, the nature of immunity, vaccine effectiveness and safety, and the need for booster shots among different communities and priority populations in Canada. The CITF Databank was developed to further enhance the impact of CITF funded studies by allowing additional research using the data collected from CITF-supported studies. The CITF Databank centralizes and harmonizes individual-level data from CITF-funded studies that have met all ethical requirements to deposit data in the CITF Databank and have completed a data sharing agreement. The CITF Databank is an internationally unique resource for sharing epidemiological and laboratory data from studies about SARS-CoV-2 immunity in different populations. The types of research that are possible with data from the CITF Databank include observational epidemiological studies, mathematical modelling research, and comparative evaluation of surveillance and laboratory methods.

自2020年4月至2023年3月，COVID-19免疫工作组（CITF）资助了120项研究，旨在生成关于SARS-CoV-2免疫的知识。这些研究涉及加拿大SARS-CoV-2感染的范围、免疫的性质、疫苗的有效性和安全性，以及加拿大不同社区和优先群体对加强针的需求。为进一步扩大CITF资助研究的成果，CITF数据库得以开发，以允许利用CITF支持的研究收集的数据进行额外的科研工作。CITF数据库集中并统一了符合所有伦理要求、同意将数据存入CITF数据库并已签订数据共享协议的CITF资助研究的个体水平数据。CITF数据库是国际上独特的资源共享平台，用于分享关于不同人群中SARS-CoV-2免疫的流行病学和实验室数据。利用CITF数据库中的数据可以进行观察性流行病学研究、数学建模研究以及监测和实验室方法的比较评估。